The fallout from the partial US government shutdown will soon hit pharma-related court cases and patent filings. Federal courts and the US Patent and Trademark Office have been using existing funds to continue operations but they will soon be running out.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?